Amneal Pharmaceuticals, founded in 2002 and headquartered in Bridgewater, New Jersey, is a publicly traded company specializing in generic and specialty pharmaceuticals. The company's core mission is to make healthy living possible by providing high-quality, affordable medications. Amneal offers a wide range of products, including an FDA-approved over-the-counter generic equivalent for Narcan® (Naloxone HCl) Nasal Spray, which is available without a prescription at major U.S. pharmacies. Their market focus spans essential medicines and innovative treatments, particularly in oncology.

Amneal Pharmaceuticals has garnered significant attention for its impactful contributions to the pharmaceutical industry. The company was co-founded by Chirag Patel and Chintu Patel, who have been instrumental in its growth. Notable investors include private equity firms and institutional investors who have supported its expansion. Key achievements include the successful launch of numerous generic drugs and specialty medications that address critical health needs. Overall, Amneal has made a substantial impact by improving access to essential medications and fostering innovation in drug development.